| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |